A research gap for rare diseases

There is an “overwhelming need” among HCPs for greater awareness, training and education on the diagnosis and available treatment options for rare diseases, researchers suggest.

Publisher Frontline Medical Communications, with patient advocacy group Global Genes, conducted the research among HCPs from 15 therapeutic specialties, as well as nurse practitioners and physician assistants.

They found a gap in the amount of resources focused on rare diseases and management strategies of these disorders.  Nearly 90% of 1,600 respondents agreed there is a need for more professional content on rare diseases, they said.

You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.